19.66 -0.61 (-3.01%)
AUXL
| Trade AUXL now with |
|
Stock Details
Last Trade:19.66 Change:-0.61 (-3.01%) Prev Close:20.27 Open: 20.26 Days Range:19.45 – 20.38 52 Week Range: 13.59 - 25.10 Volume:331616 P/E: N/AEPS:-0.78
View AllRecent Alerts 02/09/12
Recent Alert on 02/06/12 at 9:16am
Auxilium (AUXL) Appoints Andrew Koven as EVP, CAO; Mark Glickman as Sales SVP
Auxilium (AUXL) Appoints Andrew Koven as EVP, CAO; Mark Glickman as Sales SVP
Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), has announced the appointment of two executive officers, effective immediately. Andrew I. Koven has been named Executive Vice President, Chief Administrative Officer and General Counsel, and Mark A.... Read More
Recent Alert on 02/01/12 at 9:56am
Leerink Swann Boosts Price Target On Auxilium (AUXL), Sees Equal Risk/Reward
Leerink Swann Boosts Price Target On Auxilium (AUXL), Sees Equal Risk/Reward
Recent Alert on 02/01/12 at 9:56am
Leerink Swann Boosts Price Target On Auxilium (AUXL), Sees Equal Risk/Reward
Leerink Swann Boosts Price Target On Auxilium (AUXL), Sees Equal Risk/Reward
View AllRecent Press Releases
Press Release on 02/09/12 at 7:00am
Auxilium Pharmaceuticals to Announce Fourth Quarter 2011 Results and Conduct Conference Call on Thursday, February 23, 2012
Auxilium Pharmaceuticals to Announce Fourth Quarter 2011 Results and Conduct Conference Call on Thursday, February 23, 2012
View AllRecent SEC Filings
SEC Filing on 02/07/12 at 5:02pm
Form 4 AUXILIUM PHARMACEUTICALS For: Feb 03 Filed by: Glickman Mark A
Form 4 AUXILIUM PHARMACEUTICALS For: Feb 03 Filed by: Glickman Mark A
SEC Filing on 02/07/12 at 5:01pm
Form 4 AUXILIUM PHARMACEUTICALS For: Feb 03 Filed by: KOVEN ANDREW I
Form 4 AUXILIUM PHARMACEUTICALS For: Feb 03 Filed by: KOVEN ANDREW I
View AllRecent Blog Posts
Blog Posts on 01/24/12 at 3:32pm
Transcept's Intermezzo Has Significant Long Term Potential, But What About 2012?
Transcept's Intermezzo Has Significant Long Term Potential, But What About 2012?